Getting your player ready...
TRENTON, N.J. — Drugmaker Merck & Co. said it will challenge its first loss in a trial blaming its osteoporosis drug for destroying a patient’s jawbone after a federal jury on Friday awarded $8 million to the Florida woman.
The U.S. District Court jury in New York awarded that amount in compensatory damages to Shirley Boles, 72, of Fort Walton, Fla., who alleged Merck’s Fosamax destroyed her jawbone near her ears, causing serious pain and disability.
Denver Post staff and wire reports
